Upgrade to SI Premium - Free Trial

BofA Securities Upgrades Gilead Sciences (GILD) to Buy on HIV drug upside

September 8, 2023 6:05 AM
(Updated - September 8, 2023 6:40 AM EDT)

BofA Securities analyst Geoff Meacham upgraded Gilead Sciences (NASDAQ: GILD) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Comments Hot Upgrades Upgrades

Next Articles